Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Forensic Technologies Market 2017-2021 - Growing Importance of NGS - Research and Markets

Research and Markets
Posted on: 24 Nov 17

The "Global Forensic Technologies Market 2017-2021" report has been added to Research and Markets' offering.

The global forensic technologies market to grow at a CAGR of 11.82% during the period 2017-2021.

The report covers the present scenario and the growth prospects of the global forensic technologies market for 2017-2021. To calculate the market size, the report considers the revenue generated from the retail sales of forensic technology products, including instruments, reagents, and kits has been considered. The report also includes a discussion of the key vendors operating in this market.

The latest trend gaining momentum in the market is Growing importance of NGS. NGS makes the entire sequencing process more efficient by initiating parallel sequencing of DNA fragments. Huge volume of sequencing data is processed in a short period and costs less. Based on NGS technology, several assays and models have been designed for forensic DNA applications.

According to the report, one of the major drivers for this market is Increasing crime rate demanding better investigation methods. The number of crime rates and sophistication of crimes have increased worldwide, which demands advanced technology and intelligence in solving crimes.

Key vendors

  • Agilent Technologies
  • LGC
  • Promega
  • Thermo Fisher Scientific

Other prominent vendors

  • BioEnable
  • Bio-Rad Laboratories
  • GE Healthcare
  • Illumina
  • NetBio
  • NMS Labs
  • Neogen
  • Shimadzu

Key Topics Covered:

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Introduction

Part 05: Market Segmentation By Technique

Part 06: Market Opportunity By Technique

Part 07: Regional Landscape

Part 08: Decision Framework

Part 09: Drivers And Challenges

Part 10: Market Trends

Part 11: Vendor Landscape

Part 12: Vendor Analysis

Part 13: Appendix

For more information about this report visit

View source version on

Business Wire

Last updated on: 24/11/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.